₹981.05
2.45 (0.25%) ▲
as on
as on August 29, 2025 at 4:01 pm IST
Day's Low
Day's High
1.21%
Downside
0.76%
Upside
52 Week's Low
52 Week's High
18.96%
Downside
18.17%
Upside
as on August 29, 2025 at 4:01 pm IST
Market Cap
₹98,716.59 Cr
Return on Equity (ROE)
31.29
PE Ratio (TTM)
21.59
Return on capital employed (ROCE)
30.47
Industry PE ratio
42.75
Beta (LTM)
0.8
P/B Ratio
4.2
Dividend Yield
1.24
PEG Ratio
5.48
Quarterly Earnings Growth YOY
1.57
EPS (TTM)
45.87
Sector
Pharmaceuticals
Book Value
238.1
Technical Analysis
Bullish
View Technical Analysis
as on August 29, 2025 at 4:01 pm IST
Zydus Lifesciences in the last 5 years
Lowest (7.34x)
March 7, 2022
Today (21.59x)
August 29, 2025
Industry (42.75x)
August 29, 2025
Highest (34.62x)
March 26, 2024
Today’s Price to Earnings Ratio: 21.59x
Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
HOLD | 98,716.59 | 32.85% | 0.61 | 4,614 | 23,241 | |
BUY | 11,846.63 | -7.48% | 0.52 | 413 | 2,013 | |
BUY | 60,228.63 | 5.41% | 0.60 | 3,483 | 31,723 | |
BUY | 66,895.00 | 18.44% | 0.00 | 1,414 | 6,445 | |
BUY | 47,179.58 | 15.56% | 0.56 | 927 | 3,749 |
Based on 30 analysts
36.67%
Buy
40.00%
Hold
23.33%
Sell
Based on 30 analysts, 40% of analysts recommend a 'HOLD' rating for Zydus Lifesciences. Average target price of ₹1002.83
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Zydus Lifesciences.
What analysts predicted
2.22%UPSIDE
Target Price
₹1002.83
Current Price
₹981.05
Analyzed by
30 Analysts
High
₹1150
Target
₹1002.83
Low
₹850
Zydus Lifesciences target price ₹1002.83, a slight upside of 2.22% compared to current price of ₹981.05. According to 30 analysts rating.
Source: S&P Global Market Intelligence
Investment in Zydus Lifesciences Ltd Shares on INDmoney has grown by 28.37% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:28.37% versus previous 30 day period
Search interest for Zydus Lifesciences Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:7% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
Check out the Mutual Funds with significant holdings in Zydus Lifesciences.
View detailed summary of the earnings and dividend history of Zydus Lifesciences.
Zydus Lifesciences Ltd’s net profit jumped 3.3% since last year same period to ₹1,466.80Cr in the Q1 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated 25.27% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.12%.
Read More about DividendsCheck stock indices that include Zydus Lifesciences.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 5.30K Cr → 6.72K Cr (in ₹), with an average increase of 7.2% per quarter
Retail Holding Up
Retail Investor have increased holdings from 6.68% to 6.74% in Jun 2025 quarter
Best in 3 Years
In the last 3 years, ZYDUSLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
Netprofit is up for the last 4 quarters, 911.2 Cr → 1.46K Cr (in ₹), with an average increase of 14.6% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.99% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 20.4% return, outperforming this stock by 33.4%
FII Holding Down
Foreign Institutions have decreased holdings from 7.32% to 7.13% in Jun 2025 quarter
Price Dip
In the last 7 days, ZYDUSLIFE stock has moved down by -4.1%
MF Holding Down
Mutual Funds have decreased holdings from 6.36% to 5.56% in Jun 2025 quarter
Organisation | Zydus Lifesciences Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
CEO | Pankaj R Patel |
E-voting on shares | Click here to vote |
Zydus Lifesciences share price today stands at ₹981.05 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹988.5 and a low of ₹969.2.
Zydus Lifesciences touched a 52 week high of ₹1159.35 and a 52 week low of ₹795. Zydus Lifesciences share price today i.e. is closed at ₹981.05, which is -15.38% down from its 52 week high and 23.40% up from its 52 week low.
Zydus Lifesciences market capitalisation is ₹98,716.59 Cr as on .
To buy Zydus Lifesciences shares, you need to follow these steps:
Zydus Lifesciences trading volume is 8.33L as on . This means that 8.33L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.